Department of Microbiology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Isehara 259-1146, Japan.
Viruses. 2022 Jul 1;14(7):1461. doi: 10.3390/v14071461.
The spike protein (SP) of SARS-CoV-2 is an important target for COVID-19 therapeutics and vaccines as it binds to the ACE2 receptor and enables viral infection. Rapid production and functional characterization of properly folded SP is of the utmost importance for studying the immunogenicity and receptor-binding activity of this protein considering the emergence of highly infectious viral variants. In this study, we attempted to express the receptor-binding region (RBD) of SARS-CoV-2 SP containing disulfide bonds using the wheat germ cell-free protein synthesis system. By adding protein disulfide isomerase (PDI) and endoplasmic reticulum oxidase (ERO1α) to the translational reaction mixture, we succeeded in synthesizing a functionally intact RBD protein that can interact with ACE2. Using this RBD protein, we have developed a high-throughput AlphaScreen assay to evaluate the RBD-ACE2 interaction, which can be applied for drug screening and mutation analysis. Thus, our method sheds new light on the structural and functional properties of SARS-CoV-2 SP and has the potential to contribute to the development of new COVID-19 therapeutics.
新型冠状病毒(SARS-CoV-2)的刺突蛋白(SP)是 COVID-19 治疗药物和疫苗的重要靶点,因为它与 ACE2 受体结合并使病毒能够感染。考虑到高传染性病毒变体的出现,快速生产和功能表征正确折叠的 SP 对于研究该蛋白的免疫原性和受体结合活性至关重要。在这项研究中,我们试图使用小麦胚细胞无细胞蛋白合成系统表达含有二硫键的 SARS-CoV-2 SP 的受体结合区(RBD)。通过向翻译反应混合物中添加蛋白二硫键异构酶(PDI)和内质网氧化酶(ERO1α),我们成功合成了一种功能完整的 RBD 蛋白,该蛋白可以与 ACE2 相互作用。使用这种 RBD 蛋白,我们开发了一种高通量 AlphaScreen 测定法来评估 RBD-ACE2 相互作用,该测定法可用于药物筛选和突变分析。因此,我们的方法揭示了 SARS-CoV-2 SP 的结构和功能特性,并有可能为开发新的 COVID-19 治疗方法做出贡献。